For a story in KFF Health News, she told Claire Sibonney that she has seen the lives of her adult patients change dramatically during research on this drug
It refers to the quick reduction in blood glucose levels seen after starting GLP-1 receptor agonist therapy
Patient awareness gaps drive poor treatment decisions: Limited knowledge that no IV glutathione is FDA-approved for skin lightening Lack of awareness about the 32% adverse event rate including serious complications Aesthetic clinic promotion continues despite regulatory warnings from multiple countries Misconception that higher cost ($2,000-$3,200) equals better results The 2025 Philippine FDA warning states there are no published guidelines for appropriate dosing regimens
Standard titration protocol The standard titration schedule progresses through five dose levels, with each dose maintained for four weeks before escalation: Weeks 1-4: 0.25 mg once weekly (initiation dose) Weeks 5-8: 0.5 mg once weekly Weeks 9-12: 1.0 mg once weekly Weeks 13-16: 1.7 mg once weekly Week 17 onward: 2.4 mg once weekly (maintenance dose) This 16-week titration period is not optional or merely suggested
How frequently are bedside glucose levels measured in hospital inpatients on glucocorticoid treatment
Why NAD+ Feels Different on GLP-1 GLP-1 medications slow gastric emptying and change how nutrients move through your digestive system
